Latest AI and machine learning research in hemophilia for healthcare professionals.
Helicobacter pylori (H. pylori) is the most common carcinogenic pathogen worldwide. Infecting roughly 1 in 2 individuals globally, it is the leading cause of peptic ulcer disease, chronic gastritis, and gastric cancer. To investigate whether personalized treatments would be optimal for patients suffering from infection, we developed the H. pylori AI-clinician recommendation system. This system w...
The inhibition of Lysine-Specific Histone Demethylase 1 (LSD1) is a promising strategy for cancer treatment and targeting epigenetic mechanisms. This paper introduces a Probabilistic Conditional Generative Adversarial Network (Prob-cGAN), designed to predict the activity of LSD1 inhibitors. The Prob-cGAN was evaluated against state-of-the-art models using the ChEMBL database, demonstrating super...
Artificial intelligence (AI)-enabled interpretation of electrocardiogram (ECG) images (AI-ECGs) can identify patterns predictive of future adverse car...
Biologists frequently desire protein inhibitors for a variety of reasons, including use as research tools for understanding biological processes and...
Protein-ligand binding is the process by which a small molecule (drug or inhibitor) attaches to a target protein. The binding affinity, which refers...
Advancements in large language models (LLMs) allow them to address diverse questions using human-like interfaces. Still, limitations in their traini...
Molecular simulations are essential tools in computational chemistry, enabling the prediction and understanding of molecular interactions and thermo...
The identification of an effective inhibitor is an important starting step in drug development. Unfortunately, many issues such as the characterizatio...
Predictive biomarkers of treatment response are lacking for metastatic clear cell renal cell carcinoma (ccRCC), a tumor type that is treated with an...
Tumor mutational burden (TMB) is a significant predictive biomarker for selecting patients that may benefit from immune checkpoint inhibitor therapy. ...
PURPOSE: Evaluation of PD-L1 tumor proportion score (TPS) by pathologists has been very impactful but is limited by factors such as intraobserver/inte...
PURPOSE: Immune checkpoint inhibitors (ICIs) have revolutionized cancer treatment, yet their use is associated with immune-related adverse events (irA...
The accurate identification of drug-target affinity (DTA) is crucial for advancements in drug discovery and development. Many deep learning-based appr...
Drug discovery and development constitute a laborious and costly undertaking. The success of a drug hinges not only good efficacy but also acceptable ...
INTRODUCTION: Within the scope of the project, this study aimed to find novel inhibitors by combining computational methods. In order to design inhibi...
Early diagnosis, accurate assessment, and localization of peritoneal metastasis (PM) are essential for the selection of appropriate treatments and sur...
The programmed cell death protein 1 (PD-1, CD279) is an important therapeutic target in many oncological diseases. This checkpoint protein inhibits T ...
BACKGROUND: Immune checkpoint inhibitor-related pneumonitis (ICI-P) is a fatal adverse event of immunotherapy. However, there is a lack of methods to ...